Silvano Capitani focuses on Molecular biology, Cell biology, Protein kinase B, PI3K/AKT/mTOR pathway and Apoptosis. His work deals with themes such as Cell culture, Megakaryocyte, Haematopoiesis, T cell and CD34, which intersect with Molecular biology. His research combines Biochemistry and Cell biology.
His PI3K/AKT/mTOR pathway research is multidisciplinary, relying on both Cancer research and Cell growth. Silvano Capitani has researched Cancer research in several fields, including Leukemia and Internal medicine. The concepts of his Apoptosis study are interwoven with issues in Jurkat cells, Antibody, Transfection and Virology.
Silvano Capitani mostly deals with Molecular biology, Cell biology, Cancer research, Biochemistry and Protein kinase B. His studies deal with areas such as Cell culture, Nuclear matrix, Apoptosis, T cell and Gene isoform as well as Molecular biology. Silvano Capitani has included themes like Jurkat cells and Transfection in his Apoptosis study.
His Cellular differentiation research extends to the thematically linked field of Cell biology. His Cancer research study combines topics in areas such as Haematopoiesis, Immunology, Internal medicine, Metastasis and Breast cancer. Silvano Capitani focuses mostly in the field of Protein kinase B, narrowing it down to topics relating to PI3K/AKT/mTOR pathway and, in certain cases, Pharmacology, Cell growth and Cell cycle checkpoint.
His primary areas of investigation include Cancer research, Protein kinase B, PI3K/AKT/mTOR pathway, Breast cancer and Internal medicine. His research in Cancer research intersects with topics in Haematopoiesis, Hypoxia, Cancer cell, microRNA and Metastasis. His biological study spans a wide range of topics, including Targeted therapy, Leukemia and Cell growth.
Silvano Capitani combines subjects such as Immunology, Cell cycle checkpoint, Cell cycle and Pharmacology with his study of PI3K/AKT/mTOR pathway. The Internal medicine study which covers Oncology that intersects with CA15-3. His Cell biology research focuses on Signal transduction in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system
Luca M Neri;Paola Borgatti;Silvano Capitani;Alberto M Martelli;Alberto M Martelli.
Biochimica et Biophysica Acta (2002)
In Vitro Senescence and Apoptotic Cell Death of Human Megakaryocytes
Giorgio Zauli;Marco Vitale;Elisabetta Falcieri;Davide Gibellini.
An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell Dysfunction
Paola Secchiero;Federica Corallini;Assunta Pandolfi;Agostino Consoli.
American Journal of Pathology (2006)
Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis.
G. Zauli;D. Gibellini;D. Milani;M. Mazzoni.
Cancer Research (1993)
Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway
Giorgio Zauli;Davide Gibellini;Paola Secchiero;Hélène Dutartre.
Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-ζ translocation to the nucleus of NGF-treated PC12 cells
Luca M. Neri;Alberto M. Martelli;Paola Borgatti;Maria L. Colamussi.
The FASEB Journal (1999)
Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3
Paola Secchiero;Federica Corallini;Arianna Gonelli;Raffaella Dell’Eva.
Circulation Research (2007)
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells
P Secchiero;C Zerbinati;Erika Rimondi;Federica Corallini.
Cellular and Molecular Life Sciences (2004)
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells
Giorgio Zauli;Davide Gibellini;Antonella Caputo;Alessandra Bassini.
Extracellular HIV-1 Tat Protein Up-Regulates the Expression of Surface CXC-Chemokine Receptor 4 in Resting CD4+ T Cells
Paola Secchiero;Paola Secchiero;Davide Zella;Silvano Capitani;Robert C. Gallo.
Journal of Immunology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: